GlassScriptPhysician profile
Paul Michael Davis
NPI 1538123534
$18,385.01
in general payments reported to CMS, 2019-2025
36 companies · $7,737 in 2025
The $7,737 reported for 2025 was more than what 88% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,487 · 2020: $161 · 2021: $1,170 · 2022: $1,112 · 2023: $4,702 · 2024: $1,017 · 2025: $7,737.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $8,637 · Food and Beverage: $4,368 · Consulting Fee: $450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $8,637.26 |
| Food and Beverage | $4,368.06 |
| Consulting Fee | $450.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,937.31 | 2021-2025 | Endurant Iis, Valiant Captivia |
| Penumbra, INC. | $3,531.42 | 2020-2023 | Indigo System, Penumbra System |
| Endologix LLC | $2,498.36 | 2021-2025 | Endocross Device, Torus Stent Graft System |
| Cardiovascular Systems INC. | $2,350.64 | 2019-2023 | Diamondback Coronary |
| Boston Scientific Corporation | $596.03 | 2024-2025 | Varithena Administration Pack, Ekosonic |
| Philips North America LLC | $589.14 | 2019-2025 | Azurion 7 M20 |
| Janssen Pharmaceuticals, INC | $544.28 | 2019-2024 | Xarelto |
| Inari Medical, INC. | $489.57 | 2019-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Smith+Nephew, INC. | $477.43 | 2021-2025 | Renasys Touch, Stravix Pl, Grafix Pl |
| W. L. Gore & Associates, INC. | $347.81 | 2021-2025 | Gore Tag Thoracic Endoprosthesis |
| Abbott Laboratories | $251.54 | 2023-2024 | Jeti, Jeti Peripheral Catheter, Diamondback Peripheral |
| Silk Road Medical, INC. | $232.88 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Kerecis Limited | $221.33 | 2022-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Angiodynamics, INC. | $183.42 | 2022-2024 | Auryon Laser System 100-120 Vac, Alphavac |
| Surmodics, INC. | $162.60 | 2024-2025 | Pounce Venous Thrombectomy System, Pounce Thrombectomy System, Pounce Thrombectomy |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $149.56 | 2019 | |
| Mindray Ds USA, INC. | $100.91 | 2022 | |
| Bard Peripheral Vascular, INC. | $90.53 | 2022 | |
| Camber Spine Technologies LLC | $89.54 | 2021 | |
| Pfizer INC. | $87.26 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $72.47 | 2021-2023 | Eliquis |
| Kci USA, INC. | $66.40 | 2022-2023 | Prevena, V.A.C. Dermatac, V.A.C. Veraflo |
| Edwards Lifesciences Corporation | $35.61 | 2024 | |
| Contego Medical, INC | $35.16 | 2024 | |
| Acist Medical Systems, INC. | $34.52 | 2020 | |
| Terumo Medical Corporation | $31.67 | 2022 | |
| Solventum Corporation | $27.31 | 2025 | V.A.C. Veraflo Cleanse Choice, Prevena |
| Shockwave Medical, INC | $26.64 | 2020-2021 | |
| Lemaitre Vascular, INC. | $22.22 | 2020 | |
| Sanara Medtech INC. | $21.51 | 2025 | Celleraterx |
| Tactile Systems Technology INC | $20.85 | 2023 | Entre Plus, Flexitouch Plus |
| Argon Medical Devices, INC. | $18.46 | 2023 | Cleaner |
| Alon Medical Technology | $15.76 | 2024 | |
| Livanova USA, INC. | $12.66 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $12.21 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.